Analysis Finds Acthar Gel Cost-effective for MS Relapses

Analysis Finds Acthar Gel Cost-effective for MS Relapses

311072

Analysis Finds Acthar Gel Cost-effective for MS Relapses

Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS) experiencing a relapse, according to an economic analysis. Notably, the economic value of Acthar Gel was greater than that of alternative treatments — plasmapheresis and intravenous immunoglobulin — from the perspective of both the payers and society. The analysis, “Cost-effectiveness of repository corticotropin injection for the treatment of acute exacerbations in multiple sclerosis,” was published in the journal ClinicoEconomics…

You must be logged in to read/download the full post.